Skip to main content

Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

Publication ,  Journal Article
Barth, M; Xavier, AC; Armenian, S; Audino, AN; Blazin, L; Bloom, D; Chung, J; Davies, K; Ding, H; Ford, JB; Galardy, PJ; Hanna, R; Hayashi, R ...
Published in: J Natl Compr Canc Netw
November 2022

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Aggressive Mature B-Cell Lymphomas include recommendations for the diagnosis and management of pediatric patients with primary mediastinal large B-cell lymphoma (PMBL) and sporadic variants of Burkitt lymphoma and diffuse large B-cell lymphoma. PMBL is now considered as a distinct entity arising from mature thymic B-cells accounting for 2% of mature B-cell lymphomas in children and adolescents. This discussion section includes the recommendations outlined in the NCCN Guidelines for the diagnosis and management of pediatric patients with PMBL.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

November 2022

Volume

20

Issue

11

Start / End Page

1267 / 1275

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Medical Oncology
  • Lymphoma, Large B-Cell, Diffuse
  • Humans
  • Child
  • Adolescent
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Barth, M., Xavier, A. C., Armenian, S., Audino, A. N., Blazin, L., Bloom, D., … Sundar, H. (2022). Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 20(11), 1267–1275. https://doi.org/10.6004/jnccn.2022.0057
Barth, Matthew, Ana C. Xavier, Saro Armenian, Anthony N. Audino, Lindsay Blazin, David Bloom, Jong Chung, et al. “Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw 20, no. 11 (November 2022): 1267–75. https://doi.org/10.6004/jnccn.2022.0057.
Barth M, Xavier AC, Armenian S, Audino AN, Blazin L, Bloom D, et al. Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 Nov;20(11):1267–75.
Barth, Matthew, et al. “Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw, vol. 20, no. 11, Nov. 2022, pp. 1267–75. Pubmed, doi:10.6004/jnccn.2022.0057.
Barth M, Xavier AC, Armenian S, Audino AN, Blazin L, Bloom D, Chung J, Davies K, Ding H, Ford JB, Galardy PJ, Hanna R, Hayashi R, Lee-Miller C, Machnitz AJ, Maloney KW, Marks L, Martin PL, McCall D, Pacheco M, Reilly AF, Roshal M, Song S, Weinstein J, Zarnegar-Lumley S, McMillian N, Schonfeld R, Sundar H. Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 Nov;20(11):1267–1275.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

November 2022

Volume

20

Issue

11

Start / End Page

1267 / 1275

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Medical Oncology
  • Lymphoma, Large B-Cell, Diffuse
  • Humans
  • Child
  • Adolescent
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis